First-in-man study of a thinner-strut sirolimus-eluting bioresorbable scaffold (FUTURE-I): Three-year clinical and imaging outcomes.

Lei SongZhongwei SunChangdong GuanHongbing YanMengyue YuJingang CuiChaowei MuHong QiuYida TangYanyan ZhaoShubin QiaoHarry SuryapranataRunlin GaoBo Xunull null

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)

At 3-year follow-up of the FUTURE-I study, implantation of the thinner-strut Firesorb BRS appeared preliminary feasible and effective in the treatment of patients with noncomplex coronary lesions.

Keyphrases

coronary artery disease
coronary artery
heart failure
skeletal muscle
metabolic syndrome
mass spectrometry